Related Experiment Video
Updated: May 30, 2025

04:41
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
23.1K
Tau oligomers impair memory and synaptic plasticity through the cellular prion protein
Claudia Balducci1, Franca Orsini1, Milica Cerovic1
1Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.
Acta Neuropathologica Communications
|January 28, 2025
Summary
Cellular prion protein (PrPC) mediates toxic effects of tau oligomers (TauOs) in Alzheimer's disease models. Blocking this interaction may offer a new therapeutic strategy for tauopathies.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Abnormally phosphorylated tau aggregates, particularly tau oligomers (TauOs), are central to neuronal dysfunction and death in Alzheimer's disease (AD) and other tauopathies.
- The precise mechanisms by which TauOs exert neurotoxicity remain unclear, though cellular prion protein (PrPC) is implicated as a potential mediator.
Purpose of the Study:
- To investigate whether PrPC mediates the detrimental effects of TauOs on memory and synaptic plasticity.
- To determine if a direct interaction exists between TauOs and PrPC.
Main Methods:
- Comparison of TauO effects on recognition memory and long-term potentiation in wild-type (WT) and PrPC knockout (Prnp0/0) mice.
- Surface plasmon resonance to assess TauO-PrPC binding affinity.
- Immunofluorescence analysis to evaluate TauO association with PrPC-expressing cells.
Main Results:
- TauOs impaired recognition memory and long-term potentiation in WT mice, but not in Prnp0/0 mice.
- High-affinity binding (KD of 20-50 nM) was observed between TauOs and PrPC.
- TauOs showed PrPC dose-dependent association with cells and co-localization with PrPC.
Conclusions:
- PrPC mediates the neurotoxic effects of TauOs through direct interaction.
- Targeting the PrPC-TauO interaction represents a potential therapeutic strategy for AD and tauopathies.
Related Concept Videos
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
Role of Neurotransmitters in Memory
404
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
404
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Long-term Potentiation
2.7K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.7K
Alzheimer's Disease: Overview
439
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439

